London researchers first in Canada to use improved prostate cancer imaging

May. 09, 2016

New PSMA probe has potential to improve patient outcomes

Scientists at Lawson Health Research Institute are the first in Canada to capture prostate cancer images using a new molecule. Known as a Prostate Specific Membrane Antigen (PSMA) probe, the new molecule is used in Positron Emissions Tomography (PET) scans. The probe targets PSMA, a unique molecule on prostate cancer cells, to provide highly specific images for better diagnosis and management of patient disease. Read the full Media Release from Lawson Health Research Institute.

Back to Newsroom